Skip to main content
Fig. 4 | Orphanet Journal of Rare Diseases

Fig. 4

From: Cybernic treatment with wearable cyborg Hybrid Assistive Limb (HAL) improves ambulatory function in patients with slowly progressive rare neuromuscular diseases: a multicentre, randomised, controlled crossover trial for efficacy and safety (NCY-3001)

Fig. 4

Rate of change for the two-minute walk test (2MWT) for all participants. This figure shows the rate of change (%) in the primary endpoint, the 2MWT, between the treatment 1 (control, white bars) and treatment 2 (HAL, black bars), as well as the therapeutic positive effect (stripe bar) of cybernic treatment (black bar- white bar: -dA or dB) for group A or B. Group (A or B) and patient number are also shown. Asterisks (*) indicate the outpatient status during the study period. The order of treatments 1 and 2 was randomly determined by crossover design. Patients in the graph are displayed in order of the magnitude of the effect of treatment 2

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172